RxDoctor Payments Data

Steven Ballard, DO

Family Medicine · Kansas City, MONPI 1134357668

Payments from drug & device makers

$850in general payments, 2019–2025

Across 48 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$240
  • Boehringer Ingelheim$78
  • Amgen$75
  • Pfizer$67
  • Abbott$66
  • Takeda Pharmaceuticals U.S.A., Inc.$47
  • plus $279 from 14 others

What the payments were for

  • Food & beverage$850100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$850 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$103,345
Medicare patients
314
Services billed
3,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin97$137,342
OzempicSemaglutide88$92,813
EliquisApixaban30$24,517
WegovySemaglutide15$19,854
MounjaroTirzepatide12$11,334
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$8,083
PaxlovidNirmatrelvir/Ritonavir17$5,596
AbrysvoRsv Vacc, Pref A And Pref B/Pf17$5,322
Atorvastatin Calcium477$3,749
Fluticasone Propionate105$2,977
Levothyroxine Sodium238$2,524
Pantoprazole Sodium183$2,487
Losartan Potassium211$2,107
Duloxetine Hcl67$1,740
Potassium Chloride75$1,604

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$78$137,34297 claims
Novo NordiskOzempic, Wegovy$24$112,667103 claims
PfizerEliquis, Paxlovid, Abrysvo$67$35,43564 claims
Lilly USA, LLCMounjaro$31$11,33412 claims
GSKTrelegy Ellipta$15$8,08311 claims
AbbVieSynthroid$240$64615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →